Industry News
Combating drug-resistant cancers
Aug 29, 2013
Many cancer therapies function by activating proteins like Caspase-3 (CASP3) that promote cell death. Several forms of cancer develop resistance to these drugs by down regulating CASP3 through an unknown mechanism. In the absence of CASP3, tumor cells produce another cell death promoting protein CASP7, but it is rendered inactive by the X-linked inhibitor of apoptosis protein (XIAP)... Read More
Software tool developed for cancer genomics
Aug 29, 2013
Researchers at the Medical College of Wisconsin (MCW) have developed a new bioinformatics software tool designed to more easily identify genetic mutations responsible for cancers. The tool, called DrGaP, is the subject of a new paper published in the American Journal of Human Genetics. Xing Hua, Ph.D... Read More
Genomic sequencing leads to discovery of origin of hereditary east Texas bleeding disorder
Aug 29, 2013
A severe hereditary bleeding disorder was described in a large family from east Texas in 2001. The affected family members routinely had bruising, nosebleeds, massive blood loss following injury or surgery, and often required blood transfusions. Routine tests for functional components of the blood coagulation pathway did not reveal any obvious defects... Read More
What is neutropenia? What causes neutropenia?
Aug 28, 2013
Neutropenia is a blood condition, a granulocyte disorder, that characterized by a deficiency of neutrophils, a type of white blood cell that defends the body against bacterial and fungal infections. Granulocytes are a category of white blood cells. They are made in bone marrow... Read More
CE Mark approval for Seralite® announced, the world's first point-of-care diagnostic device for multiple myeloma
Aug 28, 2013
Serascience Limited, a specialist cancer diagnostics company established by a joint venture between Abingdon Health and the University of Birmingham, announces the receipt of European CE Mark approval for the commercial sale of Seralite®, its proprietary point-of-care diagnostic device for multiple myeloma... Read More
New minimally invasive technique for treating melanoma
Aug 28, 2013
At first, Krista Easom figured the little red bump on her foot was nothing more than a blister. It didn't hurt, but after a couple months, it didn't go away either. She booked an appointment with a dermatologist to have it removed. She wasn't worried... Read More
High coffee intake may help against prostate cancer
Aug 28, 2013
Consuming four or more cups of coffee a day could reduce the risk of prostate cancer recurrence and disease progression, according to a study published in the journal Cancer Causes and Control. Researchers from the Fred Hutchinson Cancer Research Center in Seattle analyzed 1,001 prostate cancer survivors from a population-based study, aged between 35 and 74 years of age... Read More
Tumor growth reduced, cancer cells crippled by disabling ether lipid generating enzyme
Aug 28, 2013
Knocking out a single enzyme dramatically cripples the ability of aggressive cancer cells to spread and grow tumors, offering a promising new target in the development of cancer treatments, according to a new study by researchers at the University of California, Berkeley... Read More
Therapeutic algorithm developed for optimal nosebleed management
Aug 28, 2013
Approximately 60 percent of people experience epistaxis, commonly known as nosebleed, at least once in their lifetime. Of those who experience nosebleed, six percent require medical treatment. A study in the September 2013 issue of Otolaryngology-Head and Neck Surgery, explores which nosebleed treatment options demonstrate the best outcomes... Read More
Providing extra oxygen to oxygen-deprived muscle following injury
Aug 28, 2013
The same compound in a common household clothes detergent shows promise as a treatment to preserve muscle tissue after severe injury. Researchers at the Wake Forest Baptist Medical Center's Institute for Regenerative Medicine hope the oxygen-generating compound could one day aid in saving and repairing limbs and tissue... Read More
Previous Page Next Page